Ajanta Pharma informs about outcome of board meeting

28 Dec 2021 Evaluate
Ajanta Pharma has informed that Board of Directors of the Company, at its meeting held today December 28, 2021, has unanimously approved Buy-back of up to 11,20,000 fully paid-up Equity Shares of face value of Rs 2 each by the Company (representing 1.29% of the total number of Equity Shares of the Company) at a price of Rs 2,550 (Rupees Two Thousand Five Hundred and Fifty only) per Equity Share payable in cash for a total consideration not exceeding Rs 285.60 crores (Rupees Two Hundred Eighty Five Crores and Sixty Lakhs only) (excluding transaction costs such as fees, brokerage, taxes, duties, etc.), which is not exceeding 10% of the total paid-up equity share capital and free reserves (including securities premium account) as per the audited financial statements of the Company for the financial year ended on March 31, 2021, through the 'Tender Offer' route.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2950.55 10.90 (0.37%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.